UK markets closed

Mereo BioPharma Group plc (MREO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.2600+0.1500 (+4.82%)
At close: 04:00PM EDT
3.2200 -0.04 (-1.23%)
After hours: 05:45PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-26,068
-29,466
-42,220
17,174
-222,996
Depreciation & amortisation
695
1,061
889
866.4669
2,179
Stock-based compensation
3,347
4,924
4,768
4,457
2,123
Change in working capital
-6,241
-1,593
-2,352
-2,490
-4,647
Other working capital
-33,613
-21,551
-48,834
-7,793
-38,646
Other non-cash items
1,697
1,840
2,103
18,097
7,121
Net cash provided by operating activities
-33,276
-21,132
-48,821
-7,071
-38,624
Cash flows from investing activities
Investments in property, plant and equipment
-337
-419
-13
-722.0558
-21.8052
Acquisitions, net
-
-
0
0
-482.44
Sales/maturities of investments
-
-
-
0
0
Other investing activities
-
-
-673
-
-
Net cash used for investing activities
654
-419
1,987
-568.1972
2,037
Cash flows from financing activities
Debt repayment
-718
-3,188
-937
-933.9488
-29,830
Common stock issued
2
11,605
0
105,990
27,442
Common stock repurchased
-
-
-
0
0
Dividends paid
0
-
0
0
0
Other financing activities
79
-444
200
-315.815
-6,795
Net cash used provided by (used for) financing activities
-1,408
7,973
200
104,802
47,340
Net change in cash
-34,030
-13,579
-46,634
97,163
10,754
Cash at beginning of period
76,415
68,182
127,398
31,675
22,278
Cash at end of period
42,385
57,421
68,182
127,265
31,984
Free cash flow
Operating cash flow
-33,276
-21,132
-48,821
-7,071
-38,624
Capital expenditure
-337
-419
-13
-722.0558
-21.8052
Free cash flow
-33,613
-21,551
-48,834
-7,793
-38,646